Dr. Serge Gauthier | | | Dr. Serge Gauthier
MD, FRCPC, PhD
Medical studies at Université de Montréal, Neurology training at McGill University, Research Fellowship at Prof. Theodore L. Sourkes laboratory, Allen Memorial Institute, Montreal. Clinical investigator and staff neurologist at the Montreal Neurological Hospital and Institute (1976-1986), Director of the McGill University Research Centre for Studies in Aging (1986-1996), Senior Scientist of the CIHR-Rx&D program (1997-2007). Currently Professor in the Departments of Neurology & Neurosurgery, Psychiatry, Medicine, at McGill University, and Director of the Alzheimer Disease Research Unit of the McGill University Research Centre for Studies in Aging, McGill University.
Contributions to research include design and implementation of randomized clinical trials in order to establish the safety and efficacy of cholinesterase inhibitors, muscarinic agonists, and agents possibly modifying progression for Alzheimer’s disease and vascular dementia. Special interests include consensus approach to the management of dementia in different stages, the ethics of research involving persons with dementia, and primary prevention strategies against cognitive decline and dementia.
| |
| |
Dr. Pedro Rosa-Neto | | |
Dr. Pedro Rosa-Neto
MD, PhD
An assistant professor of Neurology, Neurosurgery and Psychiatry at McGill University, affiliated to the Douglas Research Centre. He is a clinical neurologist with expertise in quantification of brain function using imaging techniques, in particular Positron Emission Tomography (PET). Dr. Rosa-Neto's research interests focus on imaging biomarkers for neurodegenerative diseases. He directs the laboratory for translational neuroimaging, which aims to use imaging techniques to advance the diagnosis of Alzheimer’s disease to a preclinical stage. Dr. Rosa-Neto research is funded by Alzheimer's Association USA (Alzheimer's Association Young Investigator), Canadian Foundation for innervation (CFI) , Fonds de la Recherche en Santé du Québec (FRSQ), Canadian Institutes of Health Research (CIHR) and Nussia & André Aisenstadt Foundation.
Dr. Rosa-Neto also conducts research on new treatments to prevent and treat dementia symptoms at the McGill Alzheimer's disease research Unit
| |
| |
Dr. Paolo Vitali | | |
Dr. Paolo Vitali
MD, FRCPC, PhD
A board certified neurologist (FRCPC) and neuropsychologist. He is neurologist at the CIUSSS Nord-de-l’Île-de-Montréal and at McGill University Research Centre for Studies in Aging. Dr. Vitali obtained a PhD in Clinical Psychology from University Vita-Salute San Raffaele in 2004 and in Biomedical Sciences (Neuropsychology) from Université de Montréal in 2007. His research focus was on language disorders (aphasia) and cerebral plasticity following brain damage as measured by neuroimaging techniques. Since 2005, he has been a registered neuropsychologist with the Ordre des Psychologues du Québec. After graduating from the Medical School of Université Laval in 2010, he completed a residency program in Neurology at Université de Montréal and a PGY6 training in electromyography at McGill (2015). During his clinical training in neurology, he continued his research training. In fact, as part of his residency program he completed a two-month research fellowship at the Memory and Aging Center (UCSF-San Francisco) working on the identification of early-affected brain regions responsible for language deficits in atypical forms of dementia, and a six-month research rotation at the McGill University Research Centre for Studies in Aging working on the physiopathological mechanisms underlying dementia. His research training has been funded by FRQS in 2015. He has also collaborated in research studies funded by Alzheimer’s Society and Heart and Stroke Foundation. Dr. Vitali is currently involved in the assessment and follow-up of patients presenting with neurodegenerative diseases, especially atypical dementia presenting with language impairments. He is also an investigator in the DIAN-TU-001 clinical trial (Dominantly Inherited Alzheimer Network Trials Unit study).
| |
| |
Dr. Marie-Chantal Menard | | | Dr. Marie-Chantal Menard
MD, Family Physician
Medical studies at Université de Montréal and family medicine certificate in 1990. Dr. Menard worked as a family doctor in the Canadian Army Forces from 1990 to 1995, She is now working in geriatrics and has collaborated with the MCSA since 1995. She is also working as a family doctor in St-Jean-sur-Richelieu. | |
| |
Image coming soon...
Dr. Stéphane Ledoux | | | Dr. Stéphane Ledoux
ledoux bio | |
| |
 |
| Manon Derasp, Tamar Tatigian, Jean Hall, Margaret de Chazal |
|
|
Margaret de Chazal
Registered Nurse
Research Nurse and study coordinator with expertise in Parkinson's disease and dementia clinical trials. Mrs De Chazal has extensive experience in imaging and fluid biomarker clinical trials. Mrs De Chazal administers cognitive assessments to patients with AD, and also spends part of her time conducting psychometric tests.
Jean Hall
Registered Nurse
Research Nurse and study coordinator with expertise in Parkinson's disease, dementia particularly in AD clinical trials. Mrs Hall has extensive experience in clinical trials involving genetics and fluid biomarkers. Mrs Hall administers cognitive assessments to patients with AD, and also spends part of her time conducting psychometric tests..
|
|
|
|
